Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lignocaine vs Nalbuphine for Pressor Response in Thyroid Surgery
NCT05298761Phase 1Unknown
- Sponsor
- Sheikh Zayed Medical College
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in hemodynamic instability comparing Lignocain with Nalbuphine (2 arms). Primary endpoints: Reduce stress response during intubation and hemodynamic stabilty at 10 minutes and Achieve hemodynamic stabilty and smooth intubation at 10 minutes. Status: unknown.
02
Drugs
lidocainenalbuphine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT05298761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05298761.